Abstract:This study presents a paclitaxel (PTX) based polymeric prodrug (FCPTX) using functionalized Pluronic-b-poly(epsilon-caprolactone) bearing carboxyl groups [pluronic-b-poly(epsilon-caprolactone-co-6-carboxylic-s-caprolactone), Pluronic-b-P(CL-co-CCL), FC] as the substrate by a dicyclohexylcarbodiimide/4-dimethylaminopyridine-catalyzed (DCC/DMAP-catalyzed) esterification reaction. High Performance Liquid Chromatography (HPLC) and H-1 NMR. were employed together to prove the successful reaction and confirmed the structure and composition of FCPTX. The result revealed that the 2'-OH of PTX participated in reaction and the PTX content in FCPTX was up to 18.3 wt%. The polymeric prodrug could self-assemble into micelles via an emulsion/solvent evaporation technique. Furthermore, the micelle was used as the nanomicellar carrier for delivery of free PTX. TEM and DLS were used to study the size and morphologies of the FCPTX micelles and PTX-loaded FCPTX (PTX/FCPTX) micelles. The results demonstrated that the two micelles were spherical spheres with narrow distribution and the size of PTX/FCPTX micelles was larger than that of FCPTX micelles due to the micellar core was enlarged by the loaded drug. The drug loading content (DLC) and drug loading efficiency (DLE) demonstrated that the great drug loading capability of FCPTX for free PTX which could be attributed to the fact that the excellent compatibility between drug and micellar core. The sustained in vitro release of PTX/FCPTX was due to that the forceful intermolecular interaction between conjugated PTX on the polymer and the encapsulated PTX, also, the forceful intermolecular interaction led to the high residual of PTX (only 33.0% total release after 72 h at pH 7.4). However, in the lower pH environment, the drug release was accelerated due to hydrolysis of ester bond and disaggregation of micelles. In vitro antitumor experiments showed that the cytotoxicity of the conjugated PTX was reduced due to that the 2'-OH of PTX was reacted and the drug activity was crippled. The PTX/FCPTX micelles revealed high antitumor activity due to the high cellular accumulation by micelle delivery. Subsequently, the great blood compatibility of FCPTX micelles and PTX/FCPTX micelles were obtained. All of the results demonstrated the use of the polymeric conjugated PTX as the core of the polymericrnicelles afforded an ideal affinity site for free PTX and had a marvelous potential in combination chemotherapy.

Synthesis and Properties of Self-assembling Paclitaxel Prodrug

Computational studies on self-assembled paclitaxel structures: Templates for hierarchical block copolymer assemblies and sustained drug release

Synthesis and Properties of the Poly(ε-caprolactone)-paclitaxel Prodrug

Photo-crosslinked Poly(ethylene Glycol)-B-poly(ϵ-caprolactone) Nanoparticles for Controllable Paclitaxel Release

Self-assembly of Glutamic Acid Linked Paclitaxel Dimers into Nanoparticles for Chemotherapy

Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy

Preparation of Amphiphilic Copolymers for Covalent Loading of Paclitaxel for Drug Delivery System

Poly(ether-ester Anhydride)-Based Amphiphilic Block Copolymer Nanoparticle As Delivery Devices for Paclitaxel

Hydrotropic polymer-based paclitaxel-loaded self-assembled nanoparticles: preparation and biological evaluation

Polymerizable Disulfide Paclitaxel Prodrug for Controlled Drug Delivery.

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo

Preparation and <i>in vitro</i> evaluation of amphiphilic paclitaxel small molecule prodrugs and enhancement of oral absorption

Peg-Detachable And Acid-Labile Cross-Linked Micelles Based On Orthoester Linked Graft Copolymer For Paclitaxel Release

Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs

Preparation of Copolymer Paclitaxel Covalently Linked Via a Disulfide Bond and Its Application on Controlled Drug Delivery.

Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug

Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment.

Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: Effect of PEG length on antitumor efficacy.

Pharmacokinetics and Biodistribution of Polymeric Micelles of Paclitaxel with Pluronic P105/poly(caprolactone) Copolymers.

Amphiphilic conjugates for solubilization of paclitaxel as efficient drug carriers based on hyaluronic acid and cyclodextrins

Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation in Vivo